Press Releases

Liquidia Corporation Announces Chief Executive Officer Transition

RESEARCH TRIANGLE PARK, N.C. , Dec. 14, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Damian deGoa has been appointed as Chief Executive Officer (CEO) and a director of the Company, effective immediately. He succeeds Neal F.
Dec 14, 2020

Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer

RESEARCH TRIANGLE PARK, N.C. , Nov. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Michael Kaseta has been appointed Chief Financial Officer (CFO), effective immediately. He succeeds Steve Bariahtaris who has served as Liquidia’s interim CFO since August 2020 . Mr.
Nov 30, 2020

Liquidia Closes Acquisition of RareGen

Merger   Reinforc es Company’s Commitment to Patients with PAH Paul Manning and Roger Jeffs Join Liquidia Corporation Board of Directors RESEARCH TRIANGLE PARK, N.C. , Nov. 18, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company
Nov 18, 2020

Liquidia Announces Results of Special Meeting of Stockholders

Stockholders Approve RareGen Acquisition Merger Expected to Close on   or A bout November 18 , 2020 RESEARCH TRIANGLE PARK, N.C. , Nov. 16, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and
Nov 16, 2020

Liquidia to Present at the 2020 Jefferies Virtual London Healthcare Conference

RESEARCH TRIANGLE PARK, N.C. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies , Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, today announced that Neal
Nov 12, 2020
Displaying 11 - 20 of 93